Catalogo Articoli (Spogli Riviste)

OPAC HELP

Titolo:
GUIDELINES FOR SYSTEMIC THERAPY OF EARLY-STAGE BREAST-CANCER
Autore:
BLUM JL; JONES SE; FAY JW; SENZER N; MENNEL RG;
Indirizzi:
UNIV TEXAS,TEXAS ONCOL PA,SW MED CTR,3535 WORTH ST DALLAS TX 75246
Titolo Testata:
Breast cancer research and treatment
fascicolo: 3, volume: 43, anno: 1997,
pagine: 259 - 276
SICI:
0167-6806(1997)43:3<259:GFSTOE>2.0.ZU;2-T
Fonte:
ISI
Lingua:
ENG
Soggetto:
SURGICAL ADJUVANT BREAST; GROWTH-FACTOR RECEPTOR; FOLLOW-UP; PROGNOSTIC-SIGNIFICANCE; TAMOXIFEN THERAPY; POSTMENOPAUSAL WOMEN; CELL-PROLIFERATION; ENDOMETRIAL CANCER; PRACTICE POLICIES; MEDICAL PROGRESS;
Keywords:
BREAST CANCER; TREATMENT GUIDELINES; SYSTEMIC THERAPY; PROGNOSTIC FACTORS; DOSE INTENSIFICATION; CHEMOTHERAPY; RADIATION THERAPY;
Tipo documento:
Editorial Material
Natura:
Periodico
Settore Disciplinare:
Science Citation Index Expanded
Citazioni:
120
Recensione:
Indirizzi per estratti:
Citazione:
J.L. Blum et al., "GUIDELINES FOR SYSTEMIC THERAPY OF EARLY-STAGE BREAST-CANCER", Breast cancer research and treatment, 43(3), 1997, pp. 259-276

Abstract

Optimal treatment of early stage breast cancer remains an active areaof study. An expert multidisciplinary committee reviewed clinical data on systemic therapy for early stage, stage I and II breast cancer. Guidelines for treatment were developed for Texas Oncology, P.A., the largest private practice group of oncologists in the United States. This group of physicians treats approximately 5000 new breast cancer patients each year and has a major impact on oncology care in the state ofTexas. These guidelines identify prognostic factors which help the practitioner in choosing treatment for patients. Subsets of patients areidentified for whom no systemic therapy is warrented. Standard chemotherapy and hormonal therapy regimens are outlined for patients with early stage disease at increased risk for relapse. Dose intensification for high risk stage II patients is reviewed. Timing of therapy and thesequencing of chemotherapy and radiation therapy is addressed. Strategies for the follow-up of patients with a history of breast cancer areoutlined.

ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 07/07/20 alle ore 04:48:45